| 原文 | 译文 | 详情 |
|---|---|---|
| severe asthma | 重症哮喘 | - |
| biomarker strategy group | 生物标志物策略组 | - |
| corticosteroid dose | 皮质类固醇剂量 | - |
| the control group | 对照组 | - |
| corticosteroid treatment | 激素疗效 | - |
| lung function | 肺功能 | - |
| proportion of patients | 患者比例 | - |
| personal fees | 个人费用 | - |
| treatment advisories | 治疗建议 | - |
| beclometasone dipropionate | 二丙酸倍氯米松 | - |
| uncontrolled asthma | 无法控制的哮喘 | - |
| asthma control | 哮喘控制 | - |
| PP analysis | PP分析 | - |
| Proportion of patients | 患者比例 | - |
| µg equivalent | µg当量 | - |
| electronic case-report form | 电子病例报告表 | - |
| their corticosteroid treatment | 他们的皮质类固醇治疗 | - |
| study visit | 学习访问 | - |
| primary outcome | 主要结果 | - |
| follow treatment advisories | 遵守治疗建议 | - |
| reduce corticosteroid treatment | 减少皮质类固醇治疗 | - |
| severe exacerbation | 严重加重 | - |
| the ITT population | ITT人口 | - |
| treatment advice | 治疗建议 | - |
| oral corticosteroids | 口服皮质类固醇 | - |
| treatment groups | 治疗组 | - |
| advisory boards | 咨询委员会 | - |
| study groups | 学习小组 | - |
| randomly assigned | 随机分配 | - |
| severe exacerbations | 严重恶化 | - |
| Refractory Asthma Stratification Programme | 难治性哮喘分层方案 | - |
| randomised controlled trial | 随机对照试验 | - |
| exacerbation rate | 加重率 | - |
| corticosteroid treatment dose | 皮质类固醇治疗剂量 | - |
| fractional exhaled nitric oxide | 呼出分数一氧化氮 | - |
| reduce treatment | 减少治疗 | - |
| quality of life | 生活质量 | - |
| Medical Research Council | 医学研究委员会 | - |
| Blood eosinophil count | 血嗜酸性粒细胞计数 | - |
| asthma symptoms | 哮喘症状 | - |
| no significant difference | 无显著性差异 | - |
| parallel group | 平行群 | - |
| increased risk | 风险增加 | - |
| blood eosinophils | 血嗜酸细胞 | - |
| serum periostin | 血清骨膜素 | - |
| parts per billion | 十亿分比 | - |
| odds ratio | 比数比 | - |
| study group | 研究小组 | - |
| J Respir Crit Care Med | J Respir Crit Care Med | - |
| Asthma Control | 哮喘控制 | - |
| Asthma Quality of Life Questionnaire | 哮喘生活质量问卷 | - |
| treatment group | 处理组 | - |
| standard care | 标准护理 | - |
| symptom scores | 症状评分 | - |
| forced vital capacity | 用力肺活量 | - |
| at least one | 至少一个 | - |
| severe asthma exacerbation | 严重哮喘加重 | - |
| treatment advisory | 治疗咨询 | - |
| lower dose | 低剂量 | - |
| rate ratio | 速率比 | - |
| treatment strategy | 治疗策略 | - |
| effect estimate shown | 显示效果估计 | - |
| a biomarker-based strategy | 基于生物标志物的策略 | - |
| blood eosinophil count | 血嗜酸性粒细胞计数 | - |
| number of patients | 病人人数 | - |
| biomarker profile | 生物标志物图谱 | - |
| Oral corticosteroid dose | 口服皮质类固醇剂量 | - |
| hazard ratio | 危险比 | - |
| secondary aim | 次要目标 | - |
| high-dose treatment | 大剂量治疗 | - |
| a significantly greater proportion | 更大的比例 | - |
| have been | 目前已 | - |
| corticosteroid reduction | 皮质类固醇减量 | - |
| Cumulative oral corticosteroid | 累积性口服皮质类固醇 | - |
| non-financial support | 非财政支助 | - |
| a lower corticosteroid | 低糖皮质激素 | - |
| clinical centres | 临床中心 | - |
| corticosteroid therapy | 糖皮质激素治疗 | - |
| symptomatic patients | 有症状的病人 | - |
| the eCRF software | eCRF软件 | - |
| study procedures | 研究程序 | - |
| adjust corticosteroid dose | 调整皮质类固醇剂量 | - |
| biomarker-low patients | 低生物标志物患者 | - |
| Biomedical Research Centre | 生物医学研究中心 | - |
| secondary outcomes | 次要结果 | - |
| systemic corticosteroid | 全身皮质类固醇 | - |
| the trial algorithm | 试用算法 | - |
| Secondary outcomes | 次要结果 | - |
| reduced treatment | 减量处理 | - |
| a greater proportion | 更大的比例 | - |
| no evidence | 没有证据 | - |
| lowest dose | 最低剂量 | - |
| recent exacerbation history | 近期病情加重史 | - |
| last study visit | 上次访学 | - |
| baseline randomisation visit | 基线随机访问 | - |
| post-hoc analysis | 事后分析 | - |
| adverse events | 不良事件 | - |
| Oral corticosteroid use | 口服皮质类固醇使用 | - |
| protocol-defined exacerbation | 协议定义的加重 | - |
| maintain treatment | 维持治疗 | - |
| treatment centre | 治疗中心 | - |
| smoking status | 吸烟状态 | - |
| a default advisory | 默认通知 | - |
| use of rescue | 使用救援 | - |
| Inhaled corticosteroid dose | 吸入皮质类固醇剂量 | - |
| composite score | 综合得分 | - |
| patients reducing | 减少患者 | - |
| strategy group | 战略小组 | - |
| Odds ratio | 比数比 | - |
| control symptoms | 控制症状 | - |
| reduce exacerbations | 减少病情恶化 | - |
| Time to first exacerbation | 首次加重时间 | - |
| last year | 去年 | - |
| study entry | 学习条目 | - |
| oral corticosteroid | 口服皮质类固醇 | - |
| Global Initiative for Asthma | 全球哮喘倡议 | - |
| AQLQ total score | AQLQ总分 | - |
| inhaled corticosteroid dose | 吸入皮质类固醇剂量 | - |
| Asthma Control Questionnaire | 哮喘控制问卷 | - |
| a composite biomarker | 复合生物标志物 | - |
| patients who had | 例病人 | - |
| control group | 对照组 | - |
| treatment adjustment | 治疗调整 | - |
| inhaled corticosteroid | 吸入性激素 | - |
| Control group | 对照组 | - |
| Effect estimate | 效果估计 | - |
| ill health | 健康欠佳 | - |
| Severe Asthma | 重症哮喘 | - |
| study visits | 考察访问 | - |
| dose of ICS | ICS剂量 | - |
| treatment adjusted | 待遇调整 | - |
| biomarker strategy | 生物标志物策略 | - |
| exhaled nitric oxide | 呼出一氧化氮 | - |
| Asthma exacerbations | 哮喘加重 | - |
| biomarker-based strategy | 基于生物标志物的策略 | - |
| Research Centre | 研究中心 | - |
| treatment adjustment | 治疗调整 | - |
| blood eosinophil counts | 血液嗜酸性粒细胞计数 | - |
| symptomatic patient | 有症状的病人 | - |
| treatment adjustments | 待遇调整 | - |
| Effect estimate shown | 显示效果估计 | - |
| Forced vital capacity | 用力肺活量 | - |
| PP) analysis | PP）分析 | - |
| Uncontrolled asthma | 无法控制的哮喘 | - |
| Biomarker strategy group | 生物标志物策略组 | - |
| post-hoc analyses | 事后分析 | - |
| dose of corticosteroid | 皮质类固醇剂量 | - |
| related ill health | 相关的健康不良 | - |
| lower corticosteroid dose | 低剂量皮质类固醇 | - |
| reduce corticosteroid treatment | 减少皮质类固醇治疗 | - |
| asthma exacerbation | 哮喘加重 | - |
| Smoking status | 吸烟状况 | - |
| Increased risk | 风险增加 | - |
| rescue steroid | 救护类固醇 | - |
| A default advisory | 默认通知 | - |
| rescue steroids | 救护类固醇 | - |
| reduced exacerbations | 减少病情恶化 | - |
| Followed treatment adv | 后续治疗 | - |
| Advisory Board | 咨询委员会 | - |
| Followed treatment advisories | 遵循治疗建议 | - |
| treatment strategies | 治疗策略 | - |
| secondary outcome | 次要结果 | - |
| eosinophil counts | 嗜酸性粒细胞计数 | - |
| symptom score | 症状评分 | - |
| asthma exacerbations | 哮喘加重 | - |
| beclometasone dipropionate | 二丙酸倍氯米松 | - |
| 反式 | Trans | - |
| 抑制细胞 | Suppressor cell | - |
| OE | OE | - |
| Corning | Corning | - |
| 基因转录 | Gene transcription | - |
| 细胞因子风暴 | Cytokine storm | - |
| 磷酸化水平 | Phosphorylation level | - |
| 成纤维细胞 | Fibroblasts | - |
| 培养上清 | Culture supernatant | - |
| 磷酸化 | Phosphorylation | - |
| 微生物感染 | Microbial infection | - |
| 实验组 | Experimental group | - |
| shRNA病毒 | ShRNA virus | - |
| PCR | PCR | - |
| 冠状病毒 | Coronavirus | - |
| 自身免疫疾病 | Autoimmune disease | - |
| 因子检测 | Factor detection | - |
| 扩增 | Amplification | - |
| 人上皮细胞 | Human epithelial cell | - |
| SuperMix | SuperMix | - |
| 类风湿性关节炎 | Rheumatoid arthritis | - |
| 肿瘤免疫治疗 | Tumor immunotherapy | - |
| qPCR | QPCR | - |
| 治疗靶点 | Therapeutic target | - |
| 培养板 | Culture plate | - |
| release | Release | - |
| 急性炎症 | Acute inflammation | - |
| FLS | FLS | - |
| puro | Puro | - |
| 中加入 | Add to | - |
| 室温 | Room temperature | - |
| 病毒载体 | Viral vector | - |
| 冠状病毒肺炎 | Coronavirus pneumonia | - |
| DMEM | DMEM | - |
| 细胞免疫 | Cellular immunity | - |
| 外周血单核细胞分离液 | Peripheral blood monocyte isolate | - |
| YAP | YAP | - |
| 细菌感染 | Bacterial infection | - |
| 凋亡相关 | Apoptosis-related | - |
| 抑制效果 | Inhibitory effect | - |
| Pierce | Pierce | - |
| SepMateTM管 | SepMateTM tube | - |
| 磷酸化ERK | Phosphorylated ERK | - |
| 不同量 | Different quantities | - |
| 炎症性肠病 | Inflammatory bowel disease | - |
| 测序 | Sequencing | - |
| 人外周血 | Human peripheral blood | - |
| 清液 | Clear liquid | - |
| 外周血单核细胞 | Peripheral blood monocyte | - |
| 单核细胞 | Monocyte; monocyte | - |
| 慢病毒载体 | Lentiviral vector | - |
| 测序结果 | Sequencing result | - |
| RNAiMAX | RNAiMAX | - |
| 质粒转染 | Plasmid transfection | - |
| 基因编辑技术 | Gene editing technique | - |
| 医科大学 | Medical University | - |
| ChamQ | ChamQ | - |
| 细胞系 | Cell line | - |
| 感染方法 | Infection methods | - |
| 细胞分离 | Cell isolation | - |
| 脯氨酸 | Proline | - |
| 及其他 | And others | - |
| 免疫治疗 | Immunotherapy | - |
| 调控元件 | Regulatory element | - |
| 下降时 | When descending | - |
| PE | PE | - |
| 免疫疾病 | Immune disease | - |
| 编辑技术 | Editing technique | - |
| 更准确 | More accurate | - |
| 数据差异分析 | Data variance analysis | - |
| 基因表达 | Gene expression | - |
| 差异分析 | Variance analysis | - |
| 研究发现 | The findings | - |
| blotting法 | Blotting method | - |
| 疏水 | Hydrophobic | - |
| 嘌呤霉素 | Puromycin | - |
| RPMI | RPMI | - |
| mRNA | MRNA | - |
| LPS诱导基因 | LPS-induced gene | - |
| 病毒感染 | Viral infection | - |
| SYBR | SYBR | - |
| 嵌合抗原 | Chimeric antigen | - |
| shRNA | ShRNA | - |
| 抗凝采血管 | Anticoagulant vessel harvesting | - |
| 区段 | Section | - |
| 抑制作用 | Inhibitory effect | - |
| 单核细胞系 | Monocyte cell line | - |
| 上皮细胞 | Epithelial cell | - |
| 细胞染色 | Cell staining | - |
| 细胞培养板 | Cell culture plate | - |
| 如图所示 | As shown in the figure | - |
| 病原体感染 | Pathogen infection | - |
| ELISA试剂盒 | ELISA kit | - |
| 水溶解 | Water dissolution | - |
| 人单核细胞 | Human monocyte | - |
| 试剂盒 | Kit | - |
| 革兰阴性菌 | Gram-negative bacteria | - |
| 检查点 | Checkpoint | - |
| 人白介素 | Human interleukin | - |
| 病毒肺炎 | Viral pneumonia | - |
| 流式细胞术 | Flow cytometry | - |
| 感染细胞 | Infected cells | - |
| 如图 | As shown in the figure | - |
| FITC | FITC | - |
| 敲减 | Knock down | - |
| RNA病毒 | RNA virus | - |
| MAP激酶 | MAP kinase | - |
| 最强 | The strongest | - |
| 蛋白质印迹法 | Western blot | - |
| Vacutainer | Vacutainer | - |
| 诱导激活 | Induced activation | - |
| 全培养基 | Whole culture medium | - |
| ERK | ERK | - |
| 细胞固定 | Cell fixation | - |
| ELISA | ELISA | - |
| 悬液 | Suspension | - |
| Cytokine | Cytokine | - |
| PBS | PBS | - |
| 类型细胞 | Type cell | - |
| 定量PCR | Quantitative PCR | - |
| κB | ④ B | - |
| 检测试剂盒 | Detection kit | - |
| 健康成年人 | Healthy adult | - |
| 刺激控制 | Stimulus control | - |
| 对照慢病毒 | Control lentivirus | - |
| ΝF | § F | - |
| RNA酶 | RNAase | - |
| 不同大小 | Different sizes | - |
| 抗原受体T | Antigen receptor T | - |
| 炎性刺激 | Inflammatory stimulus | - |
| 具体应用 | Specific application | - |
| 慢病毒 | Lentiviruses | - |
| 伦理委员会 | Ethics Committee | - |
| TAD | TAD | - |
| 翻译成 | Translated into | - |
| 同时加入 | Join at the same time | - |
| 抗原受体 | Antigen receptor | - |
| 信号通路 | Signal pathway | - |
| RNA | RNA | - |
| 敲低 | Knock low | - |
| 作用区域 | Active area | - |
| 委员会批准 | Approved by the Committee | - |
| Gibco | Gibco | - |
| 胎牛血清 | Fetal bovine serum | - |
| 亚型 | Subtype | - |
| ELISA法 | ELISA method | - |
| 逆转录 | Reverse transcription | - |
| PBMC | PBMC | - |
| 可溶性细胞 | Soluble cell | - |
| 白介素 | Interleukin | - |
| 蛋白含量 | Protein content | - |
| 转染试剂 | Transfection reagent | - |
| 趋化因子 | Chemotactic factor | - |
| BD | BD | - |
| Grand | Grand | - |
| 供血者 | Blood Donor | - |
| 全身性感染 | Systemic infection | - |
| 实验结果表明 | The experimental results show that | - |
| 风湿性关节炎 | Rheumatoid arthritis | - |
| gRNA | GRNA | - |
| 培养箱 | Incubator | - |
| 具体方法 | Specific methods | - |
| 纤维细胞 | Fibroblasts | - |
| 抗体标记 | Antibody labeling | - |
| 外周血 | Peripheral blood | - |
| 脂多糖 | Lipopolysaccharide | - |
| Biological | Biological | - |
| 对照组 | Control group | - |
| 危及生命 | Life-threatening | - |
| 细胞因子释放综合征 | Cytokine release syndrome | - |
| 二氧化碳培养箱 | Carbon dioxide incubator | - |
| 流式细胞术 | Flow cytometry | - |
| western | Western | - |
| 培养上清液 | Culture supernatant | - |
| 炎症疾病 | Inflammatory disease | - |
| 人外周血单核细胞 | Human peripheral blood monocyte | - |
| 炎性因子 | Inflammatory factor | - |
| FBS | FBS | - |
| guideRNA | GuideRNA | - |
| siRNA | SiRNA | - |
| KD | KD | - |
| yes | Yes | - |
| 细胞因子 | Cytokines | - |
| 细胞培养基 | Cell culture medium | - |
| 正义链 | Justice chain | - |
| 无转染试剂 | Transfection-free reagent | - |
| 精氨酸酶 | Arginase | - |
| Island | Island | - |
| BI | BI | - |
| 控制组 | Control Group | - |
| 破膜 | Rupture of membrane | - |
| 转录因子 | Transcription factor | - |
| 短肽 | Short peptide | - |
| 培养基中 | In a medium | - |
| 导致翻译 | Resulting in translation | - |
| 坏死因子 | Necrosis factor | - |
| 抑制剂 | Inhibitor | - |
| 炎症性肠炎 | Inflammatory enteritis | - |
| Lipsky | Lipsky | - |
| 电转染法 | Electrophoretic transfection | - |
| antibody | Antibody | - |
| 反义链 | Antisense chain | - |
| 关节滑膜细胞 | Articular synovial cell | - |
| 引物 | Primer | - |
| PCR | PCR | - |
| 提前终止 | Premature termination | - |
| FACSVerse | FACSVerse | - |
| 抗人 | Anti-human | - |
| 书面同意 | Written consent | - |
| 明显差异 | Significant difference | - |
| μg/ml | μ g/ml | - |
| 完全培养基 | Complete medium | - |
| siRNA | SiRNA | - |
| HiScript | HiScript | - |
| 免疫性疾病 | Immune disease | - |
| 实验结果 | Experimental results | - |
| 血单核细胞 | Blood monocyte | - |
| TNF | TNF | - |
| 肝素钠 | Heparin sodium | - |
| 抑制凋亡 | Inhibition of apoptosis | - |
| 显著增强 | Significantly enhanced | - |
| 无钙镁 | Calcium-free magnesium | - |
| 肽段 | Peptide fragment | - |
| 慢病毒感染细胞 | Lentiviral infected cell | - |
| 聚凝胺 | Polycondensation amine | - |
| 突变蛋白 | Mutant protein | - |
| 细胞培养上清液 | Cell culture supernatant | - |
| 信使RNA | Messenger RNA | - |
| 实时荧光定量 | Real-time fluorescence quantification | - |
| 新冠 | COVID-19 | - |
| 细胞增殖 | Cell proliferation | - |
| 滑膜细胞 | Synovial cell | - |
| 细胞培养 | Cell culture | - |
| cDNA | CDNA | - |
| Life | Life | - |
| ΝF-κB | F-Ⅵ B | - |
| CAR-T | CAR-T | - |
| 信号负性调控元件 | Signal negative regulating element | - |
| 提取及 | Extraction and | - |
| 片段肽 | Fragment peptide | - |
| 穿透 | Penetration | - |
| DNA酶 | DNase | - |
| PRD | PRD | - |
| 慢性炎症 | Chronic inflammation | - |
| 肿瘤坏死因子 | Tumor necrosis factor | - |
| 非配对T | Unpaired T | - |
| IBD | IBD | - |
| Trizol | Trizol | - |
| Industries | Industries | - |
| 转染 | Transfection | - |
| 表达水平 | Expression level | - |
| 荧光定量PCR | Fluorescence quantitative PCR | - |
| 质粒 | Plasmid | - |
| 自身免疫性疾病 | Autoimmune disease | - |
| 人体细胞 | Human somatic cell | - |
| 先进行活细胞 | Start with live cell | - |
| LPS | LPS | - |
| 细胞裂解液 | Cell lysate | - |
| 脯氨酸富集区 | Proline-rich region | - |
| 细胞悬液 | Cell suspension | - |
| Stem | Stem | - |
| 第二天 | The next day | - |
| 结果显示 | The results show that | - |
| Lymphoprep | Lymphoprep | - |
| 诱导基因 | Inducible gene | - |
| 小分子肽 | Small molecule peptide | - |
| 数据显示 | Data Display | - |
| 逆转录 | Reverse transcription | - |
| 参考文献 | References | - |
| 蛋白转染试剂 | Protein transfection reagent | - |
| 细胞密度 | Cell density | - |
| 用电转染法 | Electrophoretic transfection | - |
| 小时后 | Hours later | - |
| Storm | Storm | - |
| 两段 | Two paragraphs | - |
| 诺唯赞 | Nuoweizan | - |
收藏成功
(推荐电脑端登录)
右上角查看我的术语->我的标签
